Whiteaker, J.R.; Wang, T.; Zhao, L.; Schoenherr, R.M.; Kennedy, J.J.; Voytovich, U.; Ivey, R.G.; Huang, D.; Lin, C.; Colantonio, S.;
et al. Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers 2021, 13, 3843.
https://doi.org/10.3390/cancers13153843
AMA Style
Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S,
et al. Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers. 2021; 13(15):3843.
https://doi.org/10.3390/cancers13153843
Chicago/Turabian Style
Whiteaker, Jeffrey R., Tao Wang, Lei Zhao, Regine M. Schoenherr, Jacob J. Kennedy, Ulianna Voytovich, Richard G. Ivey, Dongqing Huang, Chenwei Lin, Simona Colantonio,
and et al. 2021. "Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition" Cancers 13, no. 15: 3843.
https://doi.org/10.3390/cancers13153843
APA Style
Whiteaker, J. R., Wang, T., Zhao, L., Schoenherr, R. M., Kennedy, J. J., Voytovich, U., Ivey, R. G., Huang, D., Lin, C., Colantonio, S., Caceres, T. W., Roberts, R. R., Knotts, J. G., Kaczmarczyk, J. A., Blonder, J., Reading, J. J., Richardson, C. W., Hewitt, S. M., Garcia-Buntley, S. S.,
... Paulovich, A. G.
(2021). Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Cancers, 13(15), 3843.
https://doi.org/10.3390/cancers13153843